Structure

Physi-Chem Properties

Molecular Weight:  424.22
Volume:  449.522
LogP:  5.374
LogD:  3.9
LogS:  -6.403
# Rotatable Bonds:  4
TPSA:  72.83
# H-Bond Aceptor:  5
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.646
Synthetic Accessibility Score:  4.495
Fsp3:  0.538
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.89
MDCK Permeability:  2.003290683205705e-05
Pgp-inhibitor:  0.935
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.006
30% Bioavailability (F30%):  0.003

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.016
Plasma Protein Binding (PPB):  97.37510681152344%
Volume Distribution (VD):  0.641
Pgp-substrate:  0.9465335011482239%

ADMET: Metabolism

CYP1A2-inhibitor:  0.74
CYP1A2-substrate:  0.846
CYP2C19-inhibitor:  0.914
CYP2C19-substrate:  0.463
CYP2C9-inhibitor:  0.827
CYP2C9-substrate:  0.924
CYP2D6-inhibitor:  0.83
CYP2D6-substrate:  0.684
CYP3A4-inhibitor:  0.871
CYP3A4-substrate:  0.441

ADMET: Excretion

Clearance (CL):  3.547
Half-life (T1/2):  0.039

ADMET: Toxicity

hERG Blockers:  0.024
Human Hepatotoxicity (H-HT):  0.517
Drug-inuced Liver Injury (DILI):  0.12
AMES Toxicity:  0.035
Rat Oral Acute Toxicity:  0.763
Maximum Recommended Daily Dose:  0.911
Skin Sensitization:  0.19
Carcinogencity:  0.619
Eye Corrosion:  0.003
Eye Irritation:  0.173
Respiratory Toxicity:  0.922

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC316262

Natural Product ID:  NPC316262
Common Name*:   Marfuraquinocin A
IUPAC Name:   (2R,3S)-3-[2-(2,2-dimethyl-6-methylidenecyclohexyl)ethyl]-4-hydroxy-7-methoxy-2,3-dimethyl-2H-benzo[g][1]benzofuran-6,9-dione
Synonyms:  
Standard InCHIKey:  OOGVVQMYQYWZGB-OIVWUYHGSA-N
Standard InCHI:  InChI=1S/C26H32O5/c1-14-8-7-10-25(3,4)17(14)9-11-26(5)15(2)31-24-21-16(12-19(28)22(24)26)23(29)20(30-6)13-18(21)27/h12-13,15,17,28H,1,7-11H2,2-6H3/t15-,17?,26-/m1/s1
SMILES:  C=C1CCCC(C)(C)C1CC[C@]1(C)[C@@H](C)Oc2c3c(cc(c12)O)C(=O)C(=CC3=O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3092696
PubChem CID:   73603998
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001550] Sesquiterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6655.3 Streptomyces niveus SCSIO 3406 Strain Streptomycetaceae Bacteria n.a. n.a. n.a. PMID[24251399]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT395 Cell Line SF-268 Homo sapiens IC50 = 26700.0 nM PMID[500200]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 17500.0 nM PMID[500200]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 12900.0 nM PMID[500200]
NPT397 Cell Line NCI-H460 Homo sapiens IC50 = 3700.0 nM PMID[500200]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 128.0 ug.mL-1 PMID[500200]
NPT729 Organism Micrococcus luteus Micrococcus luteus MIC > 128.0 ug.mL-1 PMID[500200]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. MIC > 128.0 ug.mL-1 PMID[500200]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. MIC = 128.0 ug.mL-1 PMID[500200]
NPT19 Organism Escherichia coli Escherichia coli MIC = 128.0 ug.mL-1 PMID[500200]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MIC = 64.0 ug.mL-1 PMID[500200]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 8.0 ug.mL-1 PMID[500200]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC316262 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC314653
0.9748 High Similarity NPC313717
0.9748 High Similarity NPC315306
0.9742 High Similarity NPC313368
0.9371 High Similarity NPC475106
0.9313 High Similarity NPC100849
0.9108 High Similarity NPC40356
0.9108 High Similarity NPC154683
0.9085 High Similarity NPC54903
0.9085 High Similarity NPC286074
0.908 High Similarity NPC120857
0.908 High Similarity NPC85047
0.908 High Similarity NPC17274
0.9036 High Similarity NPC475080
0.9006 High Similarity NPC470810
0.9 High Similarity NPC196448
0.9 High Similarity NPC201127
0.8987 High Similarity NPC87708
0.8981 High Similarity NPC470568
0.8976 High Similarity NPC118128
0.897 High Similarity NPC20734
0.8963 High Similarity NPC125465
0.8957 High Similarity NPC469395
0.8951 High Similarity NPC61382
0.8951 High Similarity NPC103816
0.8941 High Similarity NPC475656
0.8941 High Similarity NPC475148
0.8938 High Similarity NPC180924
0.8931 High Similarity NPC193200
0.8924 High Similarity NPC230848
0.8924 High Similarity NPC232645
0.8924 High Similarity NPC478148
0.8924 High Similarity NPC470569
0.8924 High Similarity NPC72958
0.8922 High Similarity NPC469393
0.8916 High Similarity NPC193698
0.8909 High Similarity NPC193222
0.8903 High Similarity NPC28632
0.8889 High Similarity NPC472618
0.8882 High Similarity NPC246647
0.8882 High Similarity NPC164110
0.8882 High Similarity NPC272196
0.8882 High Similarity NPC96342
0.8882 High Similarity NPC474637
0.8882 High Similarity NPC212967
0.8868 High Similarity NPC470340
0.8868 High Similarity NPC470353
0.8861 High Similarity NPC147735
0.8861 High Similarity NPC202595
0.8861 High Similarity NPC321896
0.8861 High Similarity NPC476185
0.8848 High Similarity NPC62444
0.8848 High Similarity NPC476255
0.8848 High Similarity NPC476056
0.8841 High Similarity NPC476822
0.8834 High Similarity NPC476929
0.8834 High Similarity NPC187354
0.8827 High Similarity NPC239118
0.8827 High Similarity NPC472617
0.882 High Similarity NPC477674
0.8812 High Similarity NPC210942
0.8812 High Similarity NPC169990
0.8812 High Similarity NPC472799
0.8812 High Similarity NPC477669
0.8805 High Similarity NPC149526
0.8805 High Similarity NPC473131
0.8805 High Similarity NPC474417
0.8805 High Similarity NPC470675
0.8797 High Similarity NPC100985
0.8797 High Similarity NPC80370
0.8797 High Similarity NPC317492
0.8797 High Similarity NPC269420
0.8797 High Similarity NPC65589
0.8797 High Similarity NPC471114
0.8797 High Similarity NPC97028
0.8797 High Similarity NPC97029
0.8797 High Similarity NPC158338
0.8797 High Similarity NPC288036
0.879 High Similarity NPC289042
0.879 High Similarity NPC118027
0.879 High Similarity NPC56433
0.879 High Similarity NPC245584
0.879 High Similarity NPC259632
0.879 High Similarity NPC312929
0.879 High Similarity NPC190648
0.879 High Similarity NPC126767
0.8788 High Similarity NPC473286
0.8782 High Similarity NPC474630
0.878 High Similarity NPC94796
0.878 High Similarity NPC473022
0.8765 High Similarity NPC158542
0.8765 High Similarity NPC281137
0.8765 High Similarity NPC282390
0.8758 High Similarity NPC148938
0.8758 High Similarity NPC297531
0.8758 High Similarity NPC213936
0.875 High Similarity NPC169018
0.8742 High Similarity NPC290954
0.8742 High Similarity NPC294646
0.8742 High Similarity NPC255641
0.8735 High Similarity NPC475109
0.8734 High Similarity NPC145467
0.8734 High Similarity NPC7025
0.8734 High Similarity NPC470460
0.8734 High Similarity NPC39195
0.8734 High Similarity NPC27221
0.8734 High Similarity NPC256672
0.8734 High Similarity NPC168085
0.8727 High Similarity NPC208120
0.8727 High Similarity NPC473313
0.8727 High Similarity NPC173587
0.8727 High Similarity NPC329669
0.8727 High Similarity NPC472278
0.8727 High Similarity NPC18100
0.8726 High Similarity NPC24136
0.8726 High Similarity NPC187282
0.8726 High Similarity NPC470570
0.8726 High Similarity NPC290133
0.8721 High Similarity NPC228209
0.872 High Similarity NPC117985
0.8718 High Similarity NPC473812
0.8718 High Similarity NPC473813
0.8712 High Similarity NPC125969
0.8712 High Similarity NPC85121
0.8712 High Similarity NPC4950
0.8712 High Similarity NPC186113
0.8712 High Similarity NPC218818
0.8704 High Similarity NPC164244
0.8704 High Similarity NPC470352
0.8704 High Similarity NPC470354
0.8704 High Similarity NPC4547
0.8698 High Similarity NPC98776
0.8698 High Similarity NPC470333
0.8698 High Similarity NPC154986
0.8696 High Similarity NPC135522
0.8696 High Similarity NPC235333
0.8696 High Similarity NPC155686
0.8696 High Similarity NPC214632
0.8688 High Similarity NPC106372
0.8688 High Similarity NPC258249
0.8688 High Similarity NPC46882
0.8688 High Similarity NPC477673
0.8688 High Similarity NPC132990
0.8688 High Similarity NPC58668
0.8688 High Similarity NPC477672
0.8683 High Similarity NPC232936
0.8679 High Similarity NPC470461
0.8679 High Similarity NPC65775
0.8679 High Similarity NPC10027
0.8678 High Similarity NPC240808
0.8675 High Similarity NPC25361
0.8675 High Similarity NPC146584
0.8675 High Similarity NPC21016
0.8675 High Similarity NPC472277
0.8675 High Similarity NPC472049
0.8675 High Similarity NPC136641
0.8671 High Similarity NPC308200
0.8671 High Similarity NPC7943
0.8671 High Similarity NPC123202
0.8671 High Similarity NPC10990
0.8671 High Similarity NPC22005
0.8671 High Similarity NPC300988
0.8667 High Similarity NPC211107
0.8667 High Similarity NPC470694
0.8662 High Similarity NPC470673
0.8662 High Similarity NPC34482
0.8662 High Similarity NPC472446
0.8662 High Similarity NPC117716
0.8662 High Similarity NPC470674
0.8662 High Similarity NPC472447
0.8659 High Similarity NPC476283
0.8659 High Similarity NPC43490
0.8659 High Similarity NPC475107
0.8655 High Similarity NPC23553
0.8655 High Similarity NPC5671
0.8655 High Similarity NPC77179
0.8655 High Similarity NPC246877
0.8654 High Similarity NPC277369
0.8654 High Similarity NPC215451
0.865 High Similarity NPC263483
0.865 High Similarity NPC44199
0.865 High Similarity NPC268360
0.8647 High Similarity NPC294149
0.8647 High Similarity NPC475398
0.8642 High Similarity NPC471116
0.8642 High Similarity NPC477687
0.8642 High Similarity NPC477671
0.8639 High Similarity NPC91650
0.8639 High Similarity NPC477529
0.8639 High Similarity NPC472620
0.8634 High Similarity NPC268992
0.8634 High Similarity NPC207624
0.8634 High Similarity NPC180944
0.8634 High Similarity NPC45934
0.8634 High Similarity NPC470337
0.8634 High Similarity NPC51824
0.8634 High Similarity NPC113608
0.8634 High Similarity NPC142308
0.8634 High Similarity NPC273483
0.8634 High Similarity NPC5871

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC316262 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8544 High Similarity NPD4378 Clinical (unspecified phase)
0.8544 High Similarity NPD2533 Approved
0.8544 High Similarity NPD2534 Approved
0.8544 High Similarity NPD2532 Approved
0.8494 Intermediate Similarity NPD6959 Discontinued
0.8466 Intermediate Similarity NPD7819 Suspended
0.8462 Intermediate Similarity NPD2800 Approved
0.8424 Intermediate Similarity NPD7075 Discontinued
0.8364 Intermediate Similarity NPD3882 Suspended
0.8354 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8354 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8303 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8294 Intermediate Similarity NPD7473 Discontinued
0.8282 Intermediate Similarity NPD6599 Discontinued
0.8214 Intermediate Similarity NPD5494 Approved
0.8165 Intermediate Similarity NPD1549 Phase 2
0.8153 Intermediate Similarity NPD6100 Approved
0.8153 Intermediate Similarity NPD6099 Approved
0.8118 Intermediate Similarity NPD6232 Discontinued
0.8101 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8101 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8089 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD1934 Approved
0.8072 Intermediate Similarity NPD6801 Discontinued
0.8063 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.8061 Intermediate Similarity NPD4380 Phase 2
0.805 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8038 Intermediate Similarity NPD2796 Approved
0.8 Intermediate Similarity NPD3226 Approved
0.7989 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD1510 Phase 2
0.7962 Intermediate Similarity NPD6651 Approved
0.7962 Intermediate Similarity NPD1607 Approved
0.7956 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7955 Intermediate Similarity NPD6559 Discontinued
0.7933 Intermediate Similarity NPD8434 Phase 2
0.7931 Intermediate Similarity NPD3818 Discontinued
0.7927 Intermediate Similarity NPD1512 Approved
0.7919 Intermediate Similarity NPD6166 Phase 2
0.7919 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7917 Intermediate Similarity NPD2801 Approved
0.7914 Intermediate Similarity NPD6799 Approved
0.7907 Intermediate Similarity NPD5710 Approved
0.7907 Intermediate Similarity NPD5711 Approved
0.7904 Intermediate Similarity NPD7411 Suspended
0.7886 Intermediate Similarity NPD5844 Phase 1
0.7882 Intermediate Similarity NPD3749 Approved
0.787 Intermediate Similarity NPD3817 Phase 2
0.784 Intermediate Similarity NPD3750 Approved
0.7834 Intermediate Similarity NPD1240 Approved
0.7824 Intermediate Similarity NPD7768 Phase 2
0.7805 Intermediate Similarity NPD1511 Approved
0.7778 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD5402 Approved
0.7764 Intermediate Similarity NPD2346 Discontinued
0.7753 Intermediate Similarity NPD7251 Discontinued
0.7746 Intermediate Similarity NPD1247 Approved
0.7719 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7714 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7709 Intermediate Similarity NPD7808 Phase 3
0.7706 Intermediate Similarity NPD5760 Phase 2
0.7706 Intermediate Similarity NPD5761 Phase 2
0.7697 Intermediate Similarity NPD6797 Phase 2
0.7697 Intermediate Similarity NPD7390 Discontinued
0.7665 Intermediate Similarity NPD920 Approved
0.7657 Intermediate Similarity NPD3926 Phase 2
0.7654 Intermediate Similarity NPD2344 Approved
0.7654 Intermediate Similarity NPD1471 Phase 3
0.764 Intermediate Similarity NPD7074 Phase 3
0.763 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD919 Approved
0.7627 Intermediate Similarity NPD3751 Discontinued
0.7622 Intermediate Similarity NPD4628 Phase 3
0.7611 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7611 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD7229 Phase 3
0.7595 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD2935 Discontinued
0.7593 Intermediate Similarity NPD1551 Phase 2
0.7584 Intermediate Similarity NPD7054 Approved
0.7569 Intermediate Similarity NPD8313 Approved
0.7569 Intermediate Similarity NPD8312 Approved
0.7561 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD1243 Approved
0.756 Intermediate Similarity NPD5403 Approved
0.7545 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7542 Intermediate Similarity NPD7472 Approved
0.7541 Intermediate Similarity NPD8150 Discontinued
0.7539 Intermediate Similarity NPD7435 Discontinued
0.7531 Intermediate Similarity NPD2799 Discontinued
0.7531 Intermediate Similarity NPD3748 Approved
0.75 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5953 Discontinued
0.7486 Intermediate Similarity NPD7286 Phase 2
0.7474 Intermediate Similarity NPD6778 Approved
0.7474 Intermediate Similarity NPD6779 Approved
0.7474 Intermediate Similarity NPD6781 Approved
0.7474 Intermediate Similarity NPD6780 Approved
0.7474 Intermediate Similarity NPD6782 Approved
0.7474 Intermediate Similarity NPD6777 Approved
0.7474 Intermediate Similarity NPD6776 Approved
0.7471 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD2309 Approved
0.7459 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7448 Intermediate Similarity NPD7696 Phase 3
0.7448 Intermediate Similarity NPD7697 Approved
0.7448 Intermediate Similarity NPD7698 Approved
0.7442 Intermediate Similarity NPD37 Approved
0.744 Intermediate Similarity NPD5401 Approved
0.7429 Intermediate Similarity NPD6234 Discontinued
0.7425 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7416 Intermediate Similarity NPD2403 Approved
0.7414 Intermediate Similarity NPD4967 Phase 2
0.7414 Intermediate Similarity NPD4965 Approved
0.7414 Intermediate Similarity NPD4966 Approved
0.741 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7409 Intermediate Similarity NPD7871 Phase 2
0.7409 Intermediate Similarity NPD7870 Phase 2
0.7399 Intermediate Similarity NPD1465 Phase 2
0.7396 Intermediate Similarity NPD6273 Approved
0.7391 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7376 Intermediate Similarity NPD8366 Approved
0.7375 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD7458 Discontinued
0.736 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD8151 Discontinued
0.7342 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD4625 Phase 3
0.731 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD7874 Approved
0.7305 Intermediate Similarity NPD7003 Approved
0.7303 Intermediate Similarity NPD3787 Discontinued
0.7296 Intermediate Similarity NPD7701 Phase 2
0.7292 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD1470 Approved
0.7273 Intermediate Similarity NPD7801 Approved
0.7268 Intermediate Similarity NPD3658 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD2313 Discontinued
0.7267 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD4749 Approved
0.7238 Intermediate Similarity NPD7228 Approved
0.7233 Intermediate Similarity NPD8491 Approved
0.7231 Intermediate Similarity NPD8320 Phase 1
0.7231 Intermediate Similarity NPD8319 Approved
0.7229 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD6696 Suspended
0.7211 Intermediate Similarity NPD4360 Phase 2
0.7211 Intermediate Similarity NPD4363 Phase 3
0.7211 Intermediate Similarity NPD6535 Approved
0.7211 Intermediate Similarity NPD6534 Approved
0.7188 Intermediate Similarity NPD7700 Phase 2
0.7188 Intermediate Similarity NPD7699 Phase 2
0.7184 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD4060 Phase 1
0.7178 Intermediate Similarity NPD943 Approved
0.7174 Intermediate Similarity NPD6765 Approved
0.7174 Intermediate Similarity NPD6764 Approved
0.7173 Intermediate Similarity NPD4361 Phase 2
0.7173 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD5405 Approved
0.7169 Intermediate Similarity NPD5406 Approved
0.7169 Intermediate Similarity NPD5404 Approved
0.7169 Intermediate Similarity NPD5408 Approved
0.7151 Intermediate Similarity NPD7199 Phase 2
0.7143 Intermediate Similarity NPD4908 Phase 1
0.7135 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD6355 Discontinued
0.7134 Intermediate Similarity NPD230 Phase 1
0.7122 Intermediate Similarity NPD7907 Approved
0.7118 Intermediate Similarity NPD7236 Approved
0.7095 Intermediate Similarity NPD8067 Phase 3
0.7089 Intermediate Similarity NPD3972 Approved
0.7056 Intermediate Similarity NPD8127 Discontinued
0.7055 Intermediate Similarity NPD3764 Approved
0.7052 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD7177 Discontinued
0.7041 Intermediate Similarity NPD6823 Phase 2
0.7041 Intermediate Similarity NPD2654 Approved
0.7037 Intermediate Similarity NPD6832 Phase 2
0.7025 Intermediate Similarity NPD1201 Approved
0.7025 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD1610 Phase 2
0.7024 Intermediate Similarity NPD5763 Approved
0.7024 Intermediate Similarity NPD5762 Approved
0.7024 Intermediate Similarity NPD4111 Phase 1
0.7024 Intermediate Similarity NPD4665 Approved
0.7021 Intermediate Similarity NPD6784 Approved
0.7021 Intermediate Similarity NPD6785 Approved
0.7019 Intermediate Similarity NPD2798 Approved
0.7015 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7015 Intermediate Similarity NPD7783 Phase 2
0.7012 Intermediate Similarity NPD8032 Phase 2
0.7011 Intermediate Similarity NPD7239 Suspended

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data